Previous reports have established an inverse relationship between the expression of ACSL4 and ERα in breast cancer, as shown both in cancer cell lines and patients’ breast tumors, and indicate that ACSL4 negatively modulates the expression of ERα3,5,9. Here, ESR1 is linked to breast cancer.